Neuraxis (NRXS) EBIAT (2022 - 2025)
Historic EBIAT for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$2.1 million.
- Neuraxis' EBIAT fell 2094.09% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year increase of 1008.94%. This contributed to the annual value of -$8.2 million for FY2024, which is 4365.43% up from last year.
- Per Neuraxis' latest filing, its EBIAT stood at -$2.1 million for Q3 2025, which was down 2094.09% from -$1.7 million recorded in Q2 2025.
- Neuraxis' EBIAT's 5-year high stood at -$13628.0 during Q4 2022, with a 5-year trough of -$8.6 million in Q3 2023.
- In the last 4 years, Neuraxis' EBIAT had a median value of -$2.1 million in 2022 and averaged -$2.3 million.
- Per our database at Business Quant, Neuraxis' EBIAT tumbled by 1158401.82% in 2023 and then soared by 7965.03% in 2024.
- Quarter analysis of 4 years shows Neuraxis' EBIAT stood at -$13628.0 in 2022, then tumbled by 11584.02% to -$1.6 million in 2023, then grew by 9.07% to -$1.4 million in 2024, then crashed by 46.61% to -$2.1 million in 2025.
- Its EBIAT stands at -$2.1 million for Q3 2025, versus -$1.7 million for Q2 2025 and -$2.3 million for Q1 2025.